This Investment Plan outlines the policy context for the New Zealand Government’s investment in the Commercialisation Partner Network Fund (CPN) and the PreSeed Accelerator Fund (PSAF).
The APEC Science Prize for Innovation, Research and Education (ASPIRE) is an annual award which recognises young scientists who have demonstrated a commitment to both excellence in scientific research, as evidenced by scholarly publication, and cooperation with scientists from other APEC member economies.
We are inviting proposals for the Transition Research Fund 2027 Projects mechanism. The focus is on enabling bold, innovative research ideas through excellent research that are deemed likely to deliver meaningful benefits for New Zealand aligned with National Pillar Priorities.
Established in 2016, the New Zealand-China Research Collaboration Centres are a mechanism to align existing cooperation and build new connections between New Zealand and Chinese researchers. In 2020, their mandate was expanded to include the coordination and support of joint research projects with China.
A 2020 Catalyst: Strategic investment in a collaborative research programme with the People’s Republic of China that aims to develop high-quality research on cutting-edge health and biomedical sciences.
MBIE has announced the two successful proposals for the 2019/20 Catalyst: Strategic investment under the New Zealand–China Strategic Research Alliance (SRA).